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Tuberous sclerosis complex (tsc) is anautosomally inherited multisystem neuro-cutaneous disorder with variable expression. It 
is characterised by various features, including benign 
tumours in the brain and other vital organs—such 
as the heart, eyes, kidneys, skin and lungs—and 
dermatological features such as hypomelanotic 
macules and shagreen patches.1 According to the 2012 
International Tuberous Sclerosis Complex Consensus 
Statements, a diagnosis of TSC is either clinical, based 
on the presence of a specific combination of major and 
minor features, or genetic, determined by mutations 
in the tuberous sclerosis (TSC) 1 or TSC2 genes.2
While a relationship between autism spectrum 
disorder (ASD) and TSC has been hypothesised 
previously, confirmation of a link between these 
conditions required more validated diagnostic tools 
for ASD. An accurate assessment of the relationship 
between these two disorders is now possible with 
the availability of standardised criteria for ASD diag-
nosis, such as those published in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-V), 
the revised Autism Diagnostic Interview™ (WPS, 
Torrance, California, USA) and the Autism Diagnos-
tic Observation Schedule™ (WPS).3 The estimated 
prevalence rate of autism in TSC patients is 
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abstract: Tuberous sclerosis complex (TSC) is a multisystem neurocutaneous disorder inherited in an 
autosomal dominant manner and characterised by benign tumours in the brain and other vital organs such as 
the heart, eyes, kidneys, skin and lungs. Links between autism spectrum disorder (ASD) and TSC have been 
postulated for many decades, with TSC considered to be one of the main syndromic causes of ASD; however, 
precise confirmation of a relationship between these two disorders required validated diagnostic tools. Fortunately, 
accurate evaluation of this relationship is now possible with standardised criteria for ASD diagnosis. We report 
three children who presented to the Sultan Qaboos University Hospital, Muscat, Oman, between 2014 and 2015 
with ASD and TSC. These cases demonstrate the spectrum of neuropsychiatric involvement in TSC and highlight 
the importance of screening children with TSC for ASD features in order to encourage the early enrolment of these 
children in educational and rehabilitation programmes.
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امللخ�ص: الت�شلب الدرين هو ا�شطراب ع�شبي جلدي متعدد يت�شم ب�شفة وراثية �ش�ئدة ويتميز بوجود اأورام حميدة يف عدة اأع�ش�ء حيوية 
ك�لدم�غ والقلب والعني والكلى واجللد والرئتني. وبحث احتم�ل وجود ا�شطراب طيف التوحد وا�شطراب الت�شلب الدرين منذ عقود طويلة, اإذ 
يعترب ا�شطراب الت�شلب الدرين اأحد اأهم املتالزم�ت امل�شببة لطيف التوحد. وعلى الرغم من ذلك ف�إن الت�أكيد الدقيق بني هذين ال�شطراب�ت 
يتطلب ويحت�ج اإىل التحقق من �شحة اأدوات الت�شخي�س. وحل�شن احلظ ف�إن التقييم والت�شخي�س الدقيق ملعرفة العالقة بني هذين ال�شطرابني 
م�شت�شفى ج�معة  التقرير ثالث ح�لت مت عالجه� يف  هذا  ويتن�ول  التوحد.  لطيف  للت�شخي�س  دقيقة  ب�شبب وجود مع�يري  اأ�شبح ممكن� 
الع�شبية  العرا�س  احل�لت طيف  هذه  تربز  ال�شطرابني.  به�ذين  و2015 م�ش�بة   2014 ع�مي  م� بني  م�شقط, عم�ن  ق�بو�س,  ال�شلط�ن 
الذين يع�نون من هذه ال�شطراب�ت لإحل�قهم  الفح�س املبكر لالأطف�ل  اأهمية و�رسورة  الدرين وتوؤكد على  والنف�شية املرتبطة ب�لت�شلب 
مبكرا يف الربامج التعليمية والت�أهيلية اخل��شة.
الكلمات املفتاحية: ا�شطراب طيف التوحد؛ الت�شلب الدرين؛ تقرير ح�لة؛ عم�ن.
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approximately 50%, a similar rate to that of other 
neurological comorbidities, such as epilepsy (84.5%) 
and intellectual disability (44%).4–6 However, despite 
this high prevalence rate, few studies have assessed 
the severity of autism among patients with TSC. This 
report describes three children with both ASD and 
TSC, illustrating the coexistence of these disorders. 
Case One
A 5-year-old girl presented to the Developmental 
Paediatrics Clinic of the Sultan Qaboos University 
Hospital (SQUH), Muscat, Oman, in 2014 with 
major speech and language delays. She demonstrated 
challenging behaviours typical of ASD, including 
impulsiveness and hyperactivity. She was described by 
her parents as a very quiet infant who rarely cried, even 
during vaccinations. When she was approximately 
one year old, the patient was noted to show poor 
response to her name and rarely make eye contact. 
By 18 months of age, there were reported delays in 
sitting, walking, speech and language. She could crawl 
by 18 months and walk without support by 20 months 
of age. When she was four years old, the patient 
experienced one febrile seizure but had since had no 
further seizures. Her father had a seizure disorder 
along with adenoma sebaceum. He was evaluated 
by brain computed tomography (CT); however, the 
findings were reportedly normal.
A clinical examination revealed a hyperactive child 
who could not speak clearly and who demonstrated 
a poor response to verbal commands. Her head 
circumference was below the third centile for her 
age. She had a shagreen patch on her lower back 
extending to the left side which measured 8 x 5 cm 
and three hypopigmented macules (two on her lower 
limbs and one on her back). Her neurological and 
systemic examinations were normal. A comprehensive 
developmental assessment indicated that she fulfilled 
the DSM-V diagnostic criteria for ASD.7 Genetic 
testing showed that there was a deletion of exon 37 
of the TSC2 gene, confirming the diagnosis of TSC. 
The patient was enrolled in a rehabilitation centre 
for children with special needs and several of her 
challenging behaviours improved without the need for 
medical therapy. 
Case Two
A 5-year-old boy presented to the Developmental 
Paediatrics Clinic at SQUH in 2014 due to concerns 
related to his language, communication and social 
milestones. At 19 months old, he was noted to have 
delayed speech, poor eye contact, poor response to his 
name, many repetitive play behaviours and restricted 
interests. He had attention problems and could not 
remain focused on specific tasks. There were no 
other reported health issues. A skin examination 
revealed three hyperpigmented spots and three 
hypomelanotic macules, with the rest of examination 
being otherwise normal. A developmental evaluation 
showed significant deficits in social interaction and 
communication in addition to significant behaviours 
and interests typical of ASD. He also fulfilled the 
DSM-V diagnostic criteria for ASD.7 
Magnetic resonance imaging (MRI) of the 
brain showed nodular heterotopias and tubers 
adjacent to the right lateral ventricle [Figure 1]. The 
clinical and MRI findings confirmed the diagnosis 
of TSC. However, genetic testing revealed no 
mutations, deletions or duplications in the TSC1 
and TSC2 genes. His mother was noted to have 
one major and one minor feature of TSC—angio-
fibromata and dental pits, respectively—which 
suggested that she also had TSC. Furthermore, two 
maternal cousins had had learning problems, with one 
also having a psychiatric disorder. The patient received 
treatment at a specialised rehabilitation centre for 
children with special needs, with notable improvement 
in his development and behaviours.
Case Three
A 1-year-old female infant presented to the Develop-
mental Paediatrics Clinic at SQUH in 2015 for a 
seizure disorder which had initially manifested at three 
months of age. On examination, she was found to have 
five hypomelanotic macules measuring 0.5 x 1.5 cm. 
 
Figure 1: T2-weighted magnetic resonance fluid-
attenuated inversion recovery sequence transverse 
image showing an isointense nodular lesion in the 
right periventricular region (arrow) of a 5-year-old 
boy with autism spectrum disorder and tuberous 
sclerosis complex.
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patient was prescribed levetiracetam and clonazepam 
for her seizures, which resulted in reasonable control.
A summary of the clinical features, radiological 
findings and family history of each case is shown 
in Table 1. Unfortunately, it was difficult to ascertain 
a correlation between MRI findings and the 
severity of autistic features in each patient due to 
limited resources.
Discussion
The clinical presentation of TSC can be variable and 
challenging. The three patients in the current report 
highlight the importance of thoroughly evaluating 
patients with features of ASD in order not to miss 
other potential causes of these disorders, such as TSC. 
Patients may present to different specialties which 
can delay diagnosis; for example, two of the patients 
in the present report were diagnosed with TSC after 
being evaluated at a paediatric developmental centre. 
All three patients in the current report fulfilled the 
clinical diagnostic criteria for both TSC and ASD; 
two patients had tubers and subependymal brain 
nodules along with major dermatological features 
of TSC, while the third patient was found to have a 
mutation in the TSC2 gene. Although the genetic 
testing of one patient did not show any mutations, 
deletions or duplications in the TSC1 and TSC2 genes, 
a lack of genetic confirmation has been reported 
An MRI brain scan demonstrated multiple cortical 
and subcortical tubers and subependymal nodules 
[Figure 2], confirming a clinical diagnosis of TSC. Her 
family history was significant for seizure disorders, 
ASD, intellectual disabilities and similar skin findings.
Both the developmental history interview and 
clinical observations of the patient revealed significant 
deficits in social interaction and communication in 
addition to typical ASD behaviours and interests. She 
fulfilled the DSM-V diagnostic criteria for ASD.7 The 
 
Figure 2: T2-weighted magnetic resonance fluid-
attenuated inversion recovery sequence transverse 
image showing ill-defined hyperintense lesions in the 
cortical-subcortical right parietal region (arrows) of a 
1-year-old female infant with autism spectrum disorder 
and tuberous sclerosis complex.
Table 1: Clinical features and radiological findings of three patients with autism spectrum disorder and tuberous 
sclerosis complex
Case 1 Case 2 Case 3
Age in years at presentation 5 5 1
Gender Female Male Female
Clinical features •ASD
•History of one febrile seizure
•Three hypomelanotic 
macules on the back and 
lower limbs







•Five hypomelanotic macules 
on the back and lower limbs
Radiological findings •Normal echocardiograph •Brain MRI showed nodular 
heterotopias and tubers in the 
right lateral ventricle
•Echocardiograph showed 
two rhabdomyomas in the 
heart
•Brain MRI showed multiple 
small cortical, subcortical and 
subependymal hamartomas 
Family history •Seizure disorder in the father
•Angiofibromata, multiple 
hypomelanotic macules and 
shagreen patches in the father 
and one of his sisters
•Multiple family members 
affected with seizure 
disorders, skin findings and 
intellectual disability on the 
father’s side
•Dental pits and 
angiofibromata in the mother
•Two maternal cousins had 
learning problems and one 
had a psychiatric disorder
•Multiple hypopigmented 
lesions in the mother
•History of epilepsy, 
mental retardation and 
hypopigmented lesions in 
four maternal uncles 
and aunts
ASD = autism spectrum disorder; MRI = magnetic resonance imaging.
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in approximately 10% of patients with a confirmed 
clinical diagnosis of TSC.2 All three patients fulfilled 
the DSM-V diagnostic criteria for ASD.7
A wide range of neuropsychiatric disorders have 
been observed in patients with TSC, with an estimated 
lifetime prevalence of approximately 90%.8,9 The assoc- 
iation of TSC with ASD has been documented in 
various studies; one study reported that 1–4% of 
autistic patients may have TSC while another indicated 
that the rate of autism among TSC patients could be 
as high as 36%.10,11 The coexistence of TSC and ASD 
seems to be underestimated worldwide, mostly due 
to the under-reporting of both of these conditions. 
There is currently a worldwide initiative to introduce 
a TSC-associated neuropsychiatric disorders (TAND) 
checklist to help evaluate TSC patients.8 The findings 
of an international tuberous sclerosis registry shows 
that, even in expert TSC centres, patients are often 
inadequately examined for ASD and TAND features.12 
Hopefully, the exponentially increasing amount 
of research being conducted on neuropsychiatric 
comorbidities associated with TSC will lead to an 
improvement in TAND detection rates and, eventually, 
individualised treatment and rehabilitation plans for 
affected patients.13 
The pathophysiological mechanisms leading to 
neurological manifestations in TSC patients include 
disorganised cell growth and motility, altered 
axon outgrowth, abnormal synapse formation and 
impaired myelination, leading to disorganisation of 
the central nervous system architecture and neuronal 
connectivity.14–16 Three proteins (TSC1, TSC2 and 
Tre2-Bub2-Cdc16 domain family member 7) form 
a complex which acts as a guanosine triphosphate 
phosphohydrolase (GTP)-activating protein. Muta- 
tions in the TSC1 or TSC2 genes result in accum-
ulation of the GTP-bound protein which stimulates 
mammalian target of rapamycin (mTOR).17 Designed 
transgenic models of TSC have been used to enhance 
understanding of ASD; homozygous knock-out 
mice with TSC1 and TSC2 mutations displayed 
an autistic-like phenotype with social impairment, 
restrictive behaviours and abnormal vocalisations.18,19 
Heterozygous TSC1 or TSC2 knock-out mice have 
also shown cognitive and social deficits, even in the 
absence of gross neuropathological changes.18,19
Neuropsychiatric manifestations of TSC are 
among the most difficult to manage for patients, 
parents and caregivers, as management is often 
multidisciplinary and requires multiple interventions 
directed towards rehabilitation.20,21 Recent research 
has changed the outlook for patients with TSC 
and associated manifestations. Molecular-targeted 
treatments using mTOR inhibitors such as rapamycin 
and everolimus are promising interventions, aimed 
at relieving cognitive and neurodevelopmental feat-
ures of TSC.22 In addition to its antiproliferative and 
immunosuppressive properties, rapamycin inhibits 
mTOR, reversing the process that occurs due to TSC1 
and TSC2 mutations. Three clinical trials are currently 
exploring the use of everolimus for patients with 
neurocognitive manifestations of TSC.22 
Vigilant assessment of ASD in patients with 
TSC is essential. Additionally, new advances in diag-
nostic and screening tools available for assessing 
TAND in ASD patients with TSC should lead to the 
mandatory screening of TSC patients for associated 
features.8 It is imperative that paediatricians carry 
out detailed examinations of children with ASD in 
order to identify any associated disorders and provide 
an accurate recurrence risk assessment for other 
family members.23 Moreover, children with TSC 
should undergo screening for features of ASD; early 
interventions in the form of rehabilitation or therapy 
are recommended to improve the outcomes for and 
the quality of life of ASD patients with TSC and 
reduce the burden of this disease on affected families 
and society as a whole.
Conclusion
The current report highlights the spectrum of 
neuro-psychiatric involvement in TSC by describing 
three children with both ASD and TSC. It is of vital 
importance that children with TSC be screened for 
coexisting ASD features in order to encourage the 
rapid implementation of educational and rehabi-
litation measures.
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